SCHEMBL799896

SCHEMBL799896

CC(C)OC(=O)Nc1ccccc1Cl

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.70
HPGD P15428 2/20 0.54
ALOX15 P16050 1/20 0.54
TAS1R3 Q7RTX0 1/20 0.54
TAS1R1 Q7RTX1 1/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
CYP1A2 P05177 2/20 0.51
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
HTT P42858 1/20 0.51
CYP2C19 P33261 1/20 0.50
GRM5 P41594 1/20 0.50
MAOB P27338 1/20 0.50
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
GAA P10253 1/20 0.48
ATM Q13315 1/20 0.48
ANPEP P15144 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13299580 0.84 SMN1; SMN2 (0.56) SMN1; SMN2TAS1R3TAS1R1MEN1KMT2A
SCHEMBL27448738 0.84 KCNQ2 (0.54) SMN1; SMN2TAS1R3TAS1R1MEN1KMT2A
SCHEMBL19388858 0.84 SMN1; SMN2 (0.56) SMN1; SMN2TAS1R3TAS1R1MEN1KMT2A
SCHEMBL513878 0.82 MEN1 (0.58) SMN1; SMN2HPGDMEN1KMT2ACYP1A2
SCHEMBL11798134 0.81 NPC1 (0.58) SMN1; SMN2HPGDKDM4EALDH1A1MAOB
SCHEMBL7256712 0.81 GAA (0.56) SMN1; SMN2HPGDALOX15MEN1KMT2A
SCHEMBL7255889 0.80 HPGD (0.54) SMN1; SMN2HPGDALOX15KMT2ACYP1A2
SCHEMBL11801237 0.80 HPGD (0.59) SMN1; SMN2HPGDALOX15MEN1KMT2A
SCHEMBL11794832 0.80 HPGD (0.59) SMN1; SMN2HPGDALOX15MEN1KMT2A
SCHEMBL7305243 0.79 ANPEP (0.52) SMN1; SMN2TAS1R3TAS1R1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7635665-B2 applying aerosols of isopropyl-N-(chlorophenyl) carbamate to a stored potatoes crop, and aerosol may be generated by any suitable means using thermal aerosol generators or cool aerosol generators ( use of air in the generation of the aerosol and, or the cooling of the aerosol) KEIM JOHN RAYMOND 2009-12-22 US claimed
US-5932609-A Pharmaceutical composition for inhibiting the growth of cancers THE PROCTER & GAMBLE COMPANY (US) 1999-08-03 US claimed
US-4857345-A Compositions for the treatment of fruit and vegetables by thermal fogging and processing method using said composition XEDA INTERNATIONAL (FR) 1989-08-15 US claimed
EP-0161989-B1 COMPOSITIONS FOR THE TREATMENT OF FRUITS AND VEGETABLES BY THERMAL FOGGING AND TREATMENT PROCESS USING THESE COMPOSITIONS XEDA INTERNATIONAL (FR) 1988-08-10 EP claimed
US-20170355997-A1 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-12-14 US disclosed
US-20170355997-A1 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-12-14 US disclosed
US-9771592-B2 Methods and compositions for treating or preventing pruritis THE JOHNS HOPKINS UNIVERSITY (US) 2017-09-26 US disclosed
US-9771592-B2 Methods and compositions for treating or preventing pruritis THE JOHNS HOPKINS UNIVERSITY (US) 2017-09-26 US disclosed
US-20140303231-A1 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS THE JOHNS HOPKINS UNIVERSITY (US) 2014-10-09 US disclosed
WO-2012177971-A2 POTATO BOX STORE CHEMICAL TREATMENTS 1,4 GROUP, INC. (US) 2012-12-27 WO disclosed
US-20120328767-A1 POTATO BOX STORE CHEMICAL TREATMENTS 1,4 GROUP, INC. (US) 2012-12-27 US disclosed
US-20120073001-A1 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS THE JOHNS HOPKINS UNIVERSITY (US) 2012-03-22 US disclosed
CN-1165143-A Phosphosulfonate herbicides ROHM & HAAS (US) 1997-11-19 CN disclosed
CN-1165144-A Phosphosulfonate herbicides ROHM & HAAS (US) 1997-11-19 CN disclosed
US-4857345-A Compositions for the treatment of fruit and vegetables by thermal fogging and processing method using said composition XEDA INTERNATIONAL (FR) 1989-08-15 US disclosed
EP-0161989-B1 COMPOSITIONS FOR THE TREATMENT OF FRUITS AND VEGETABLES BY THERMAL FOGGING AND TREATMENT PROCESS USING THESE COMPOSITIONS XEDA INTERNATIONAL (FR) 1988-08-10 EP disclosed
EP-0161989-A1 Compositions for the treatment of fruits and vegetables by thermal fogging and treatment process using these compositions XEDA INTERNATIONAL (FR) 1985-11-21 EP disclosed
EP-0032733-B1 PROCESS FOR PREPARING POLYMETHYLENE POLYPHENYL POLYCARBAMATES MITSUI TOATSU CHEMICALS, Inc. (JP) 1984-06-13 EP disclosed
EP-0032733-A1 Process for preparing polymethylene polyphenyl polycarbamates MITSUI TOATSU CHEMICALS, Inc. (JP) 1981-07-29 EP disclosed
US-3938986-A ISOPROPYL N-PHENYLCARBAMATE OR ISOPROPYL N-(3-CHLOROPHENYL)CARBAMATE AND 4-CHLOROPHENYL N-METHYLCARBAMATE PPG INDUSTRIES, INC. (US) 1976-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355997-A1 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS ITCH, CCL11, CPA3 SMN1; SMN2 3785/4885HPGD 503/4885ALOX15 158/4885
US-20140303231-A1 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS ITCH, CCL11, CPA3 SMN1; SMN2 3785/4885HPGD 503/4885ALOX15 158/4885
US-20120073001-A1 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS ITCH, CCL11, CPA3 SMN1; SMN2 3785/4885HPGD 503/4885ALOX15 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.